Enteromedics Inc.
(ETRM) A medical device company developing neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
4th quarter FY2012, 12/31
20122011
Revenue$0.0$0.0—
Income–7.0–8.1—
Earn/share–0.17–0.22—
12 months
Revenue$0.3$0.0—